Suchergebnisse - "Kawashima, Yosuke"

PubPharm (51)

1

Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation : A real-world study (HOT2101)

enthalten in: Cancer science | 2024

von Tsuji, K. | Mizugaki, H. | Yokoo, K. | +22

2

Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab : A Case Report

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Shiraishi, Y. | Tokito, T. | Toyozawa, R. | +5

3

Successful application of lorlatinib in a 23-year-old patient with anaplastic lymphoma kinase (ALK)-positive lung cancer and multiple brain metastases

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Murakami, Y. | Kawashima, Y. | Chiba, S. | +13

4

Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma

enthalten in: JTO clinical and research reports | 2024

von Hazama, D. | Nakahama, K. | Kodama, H. | +18

5

First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations : The UNICORN Phase 2 Nonrandomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Okuma, Y. | Kubota, K. | Shimokawa, M. | +9

CommentOn: JAMA Oncol. 2024 Jan 1;10(1):52-53. - PMID 37991771

6

Successful application of lorlatinib in a 23‐year‐old patient with anaplastic lymphoma kinase ( ALK)‐positive lung cancer and multiple brain metastases

enthalten in: Cancer Reports | 2024

von Murakami, Y. | Kawashima, Y. | Chiba, S. | +13

7

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan : The NINJA Study

enthalten in: JTO clinical and research reports | 2023

von Murata, Y. | Tanzawa, S. | Misumi, T. | +38

8

Efficacy of paclitaxel-carboplatin with bevacizumab as a late-line therapy for patients with advanced nonsquamous non-small cell lung cancer : A platinum rechallenge

enthalten in: Thoracic cancer | 2023

von Sugisaka, J. | Toi, Y. | Kawashima, Y. | +7

9

Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer : North Japan lung cancer group 1101

enthalten in: Thoracic cancer | 2023

von Kawashima, Y. | Ishimoto, O. | Miyauchi, E. | +5

10

A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non‑small cell lung cancer : North Japan Lung Cancer Study Group 2202

enthalten in: Oncology letters | 2023

von Inomata, M. | Kawashima, Y. | Saito, R. | +10

1
2
3
4
5
6
Nächster »
[6]